Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Contribution of APOE promoter polymorphisms to Alzheimer's disease risk.
Lambert JC, Araria-Goumidi L, Myllykangas L, Ellis C, Wang JC, Bullido MJ, Harris JM, Artiga MJ, Hernandez D, Kwon JM, Frigard B, Petersen RC, Cumming AM, Pasquier F, Sastre I, Tienari PJ, Frank A, Sulkava R, Morris JC, St Clair D, Mann DM, Wavrant-DeVrièze F, Ezquerra-Trabalon M, Amouyel P, Hardy J, Haltia M, Valdivieso F, Goate AM, Pérez-Tur J, Lendon CL, Chartier-Harlin MC. Lambert JC, et al. Among authors: wavrant devrieze f. Neurology. 2002 Jul 9;59(1):59-66. doi: 10.1212/wnl.59.1.59. Neurology. 2002. PMID: 12105308
ApoE epsilon3-haplotype modulates Alzheimer beta-amyloid deposition in the brain.
Myllykangas L, Polvikoski T, Reunanen K, Wavrant-De Vrieze F, Ellis C, Hernandez D, Sulkava R, Kontula K, Verkkoniemi A, Notkola IL, Hardy J, Perez-Tur J, Haltia MJ, Tienari PJ. Myllykangas L, et al. Am J Med Genet. 2002 Apr 8;114(3):288-91. doi: 10.1002/ajmg.10202. Am J Med Genet. 2002. PMID: 11920850
No association between the alpha-2 macroglobulin I1000V polymorphism and Alzheimer's disease.
Wavrant-DeVrièze F, Rudrasingham V, Lambert JC, Chakraverty S, Kehoe P, Crook R, Amouyel P, Wu W, Holmans P, Rice F, Pérez-Tur J, Frigard B, Morris JC, Carty S, Cottel D, Tunstall N, Lovestone S, Petersen RC, Chartier-Harlin MC, Goate A, Owen MJ, Williams J, Hardy J. Wavrant-DeVrièze F, et al. Neurosci Lett. 1999 Mar 5;262(2):137-9. doi: 10.1016/s0304-3940(99)00035-x. Neurosci Lett. 1999. PMID: 10203250
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease.
Chapuis J, Hot D, Hansmannel F, Kerdraon O, Ferreira S, Hubans C, Maurage CA, Huot L, Bensemain F, Laumet G, Ayral AM, Fievet N, Hauw JJ, DeKosky ST, Lemoine Y, Iwatsubo T, Wavrant-Devrièze F, Dartigues JF, Tzourio C, Buée L, Pasquier F, Berr C, Mann D, Lendon C, Alpérovitch A, Kamboh MI, Amouyel P, Lambert JC. Chapuis J, et al. Among authors: wavrant devrieze f. Mol Psychiatry. 2009 Nov;14(11):1004-16. doi: 10.1038/mp.2009.10. Epub 2009 Feb 10. Mol Psychiatry. 2009. PMID: 19204726 Free PMC article.
Genetic studies on chromosome 12 in late-onset Alzheimer disease.
Wu WS, Holmans P, Wavrant-DeVrièze F, Shears S, Kehoe P, Crook R, Booth J, Williams N, Pérez-Tur J, Roehl K, Fenton I, Chartier-Harlin MC, Lovestone S, Williams J, Hutton M, Hardy J, Owen MJ, Goate A. Wu WS, et al. JAMA. 1998 Aug 19;280(7):619-22. doi: 10.1001/jama.280.7.619. JAMA. 1998. PMID: 9718053
Alpha-2 macroglobulin gene and Alzheimer disease.
Rudrasingham V, Wavrant-De Vrièze F, Lambert JC, Chakraverty S, Kehoe P, Crook R, Amouyel P, Wu W, Rice F, Pérez-Tur J, Frigard B, Morris JC, Carty S, Petersen R, Cottel D, Tunstall N, Holmans P, Lovestone S, Chartier-Harlin MC, Goate A, Hardy J, Owen MJ, Williams J. Rudrasingham V, et al. Nat Genet. 1999 May;22(1):17-9; author reply 21-2. doi: 10.1038/8726. Nat Genet. 1999. PMID: 10319854 No abstract available.
42 results